Literature DB >> 11805349

Comparison of nebulized adrenaline versus salbutamol in wheeze associated respiratory tract infection in infants.

Madhusmita Som Ray1, Varinder Singh.   

Abstract

OBJECTIVE: (i) To assess the efficacy of bronchodilators in wheeze associated respiratory tract infection (WRTI); and (ii) To compare L-adrenaline with salbutamol in wheeze associated respiratory tract infection.
DESIGN: Randomized controlled trial.
METHOD: Ninety one children in age group of 2 months to 2 years with their 1st or 2nd episode of wheezing in association with fever and/or coryza were enrolled. Of these, 45 received L-adrenaline (0.1ml/kg/dose in 1 in 10,000 solution) (Group A) and 46 received salbutamol (0.1mg/kg/dose) (Group B). Three doses of each drug were given, nebulized with oxygen at 20 minutes intervals. Respiratory rate, RDAI score, clinical status and pulse oxymetry was recorded before intervention and 10 minutes after each dose. Patients who showed significant relief were discharged after an observation period of three hours while those who did not were admitted.
RESULTS: Both L-adrenaline and salbutamol caused significant improvement in mean symptom score and oxygenation. However, the adrenaline group showed a significantly better improvement in the study parameters than the salbutamol group. More children in the adrenaline group could be sent home after the emergency treatment.
CONCLUSION: Adrenergic agonists both specific and non specific are beneficial in WRTI. Adrenaline is more effective than salbutamol and is thus a better, inexpensive and relatively safe alternative.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11805349

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  10 in total

Review 1.  Evidence based treatment of bronchiolitis.

Authors:  G R Sethi; Gaurav Nagar
Journal:  Indian J Pediatr       Date:  2004-08       Impact factor: 1.967

2.  Approach to a child with lower airway obstruction and bronchiolitis.

Authors:  Sudhanshu Grover; J Mathew; Arun Bansal; Sunit C Singhi
Journal:  Indian J Pediatr       Date:  2011-05-28       Impact factor: 1.967

Review 3.  Bronchodilators for bronchiolitis.

Authors:  Anne M Gadomski; Melissa B Scribani
Journal:  Cochrane Database Syst Rev       Date:  2014-06-17

4.  Comparision of Nebulised Salbutamol and L-epinephrine in First Time Wheezy Children.

Authors:  B M John; D Singh
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  Efficacy of Nebulised Epinephrine versus Salbutamol in Hospitalised Children with Bronchiolitis.

Authors:  B M John; S K Patnaik; P L Prasad
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Comparison of epinephrine to salbutamol in acute bronchiolitis.

Authors:  Mohammad-Reza Modaressi; Asadola Asadian; Jamal Faghihinia; Mehrshad Arashpour; Firoozeh Mousavinasab
Journal:  Iran J Pediatr       Date:  2012-06       Impact factor: 0.364

7.  Racemic epinephrine compared to salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial [ISRCTN46561076].

Authors:  Joanne M Langley; Michael B Smith; John C LeBlanc; Heather Joudrey; Cecil R Ojah; Paul Pianosi
Journal:  BMC Pediatr       Date:  2005-05-05       Impact factor: 2.125

8.  American Academy of Pediatrics 2014 bronchiolitis guidelines: bonfire of the evidence.

Authors:  Paul Walsh; Stephen J Rothenberg
Journal:  West J Emerg Med       Date:  2015-01-12

9.  Comparison of nebulized epinephrine to albuterol in bronchiolitis.

Authors:  Paul Walsh; John Caldwell; Kemedy K McQuillan; Steven Friese; Dale Robbins; Stephen J Rothenberg
Journal:  Acad Emerg Med       Date:  2008-04       Impact factor: 3.451

10.  Effectiveness of 3% hypertonic saline nebulization in acute bronchiolitis among Indian children: A quasi-experimental study.

Authors:  Harsh V Gupta; Vivek V Gupta; Gurmeet Kaur; Amitoz S Baidwan; Pardeep P George; Jay C Shah; Kushal Shinde; Ruku Malik; Neha Chitkara; Krushnan V Bajaj
Journal:  Perspect Clin Res       Date:  2016 Apr-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.